证券代码：601117 股票简称：中国化学 公告编号：临 2025-021 中国化学工程股份有限公司 关于经营情况简报的公告 | 地区 | 合同金额 | | --- | --- | | 境内 | 1048.83 | | 境外 | 181.34 | | 合计 | 1230.17 | 三、 重大合同列示 4 月，公司单笔合同额在人民币 5 亿元以上的重大合同主要 如下： | 序 号 | 单位名称 | 项目合同名称 | 合同金额 | | --- | --- | --- | --- | | | 中国五环工程有限公 司、中国化学工程第 | 甘肃巨化新材料有限公司高性能硅 | | | 1 | 十三建设有限公司、 | 氟新材料一体化项目标段六 EPC 工 | 13.10 | | | 中国化学工程第四建 | 程总承包合同 | | | | 设有限公司 | | | | | 中国化学工程第三建 | 伊泰伊犁能源有限公司 100 万吨/年 | | | 2 | 设有限公司 | 煤制油项目示范项目工艺主装置一 | 6.78 | | | | 标段建安工程合同 | | | | 中国化学工程第十一 | 伊泰伊犁能源有限公司 100 万吨/年 ...

Key Recommendations - Three-Dimensional Chemical (002469.SZ) benefits from accelerated coal chemical construction in Xinjiang, with a unique competitive advantage through "engineering + industry" collaboration [10][11] - Kangguan Technology (001308.SZ) shows high growth in innovative display products, with improved gross margin in Q1 2025 [12][13] Industry and Company Analysis - Three-Dimensional Chemical is a leader in sulfur recovery, leveraging proprietary technology to break foreign monopolies, with projected engineering revenue of 570 million yuan and chemical product revenue of 1.81 billion yuan in 2024 [10][11] - The company has a strong order backlog of 1.67 billion yuan, ensuring sustained revenue growth from coal chemical projects, with expected engineering revenue of 360 million, 550 million, and 760 million yuan from 2025 to 2027 [11] - The domestic market for n-propanol remains tight, with a projected supply gap of 41,000 tons in 2025, maintaining prices between 8,000-9,000 yuan/ton [11] - Kangguan Technology's Q1 2025 revenue reached 3.142 billion yuan, a year-on-year increase of 10.8%, with a net profit of 215 million yuan, reflecting a 15.8% increase [12][13] - The company’s innovative display products saw a 50.4% revenue increase in Q1 2025, driven by strong demand in emerging markets [13][14] Macroeconomic and Strategic Insights - The high-tech manufacturing sector shows signs of recovery, with a narrowing decline in the macroeconomic diffusion index, indicating improved economic conditions [15][17] - The macroeconomic environment is expected to support growth in sectors like coal chemical engineering and innovative display technologies, with favorable government policies promoting urban renewal and infrastructure investment [26][27]

【导读】中国化学（601117）孙公司涉康得新证券虚假陈述责任纠纷诉讼 5月15日，中国化学工程股份有限公司（以下简称中国化学）发布公告称，孙公司中国化学赛鼎宁波工程有限公司（以下简称赛鼎 宁波）近日收到江苏省苏州市中级人民法院送达的《应诉通知书》，获悉赛鼎宁波涉及浙江中泰创赢资产管理有限公司（以下简称 中泰创赢）起诉康得新复合材料集团股份有限公司（以下简称康得新）证券虚假陈述责任纠纷诉讼。 中国化学表示，经初步核实，赛鼎宁波不存在明知康得新实施财务造假而依然配合的情形。 公告显示，中国化学孙公司赛鼎宁波近日收到江苏省苏州市中级人民法院送达的《应诉通知书》。 原告中泰创赢称，其于2016年11月起持续投资购买康得新股票，截至2021年5月减持完毕，上述投资发生损失。原告中泰创赢请求 法院判令被告一（康得新）支付因其虚假陈述造成的投资差额损失约51.47亿元，投资差额损失部分的佣金约154.42万元，印花税约 514.73万元。另有十位其他被告。 赛鼎宁波是共同被告中的第七被告。原告中泰创赢称，除被告一外，赛鼎宁波等十位被告在本案中对原告应承担的给付义务承担连 带赔偿责任。 截至5月15日收盘，中国化学股价报8 ...

Core Viewpoint - China Chemical (601117.SH) announced that its subsidiary, China Chemical Sading Ningbo Engineering Co., Ltd., is involved in a lawsuit concerning securities fraud against Kangde Xin Composite Materials Group Co., Ltd. [1][3] Group 1: Lawsuit Details - Zhejiang Zhongtai Chuangying Asset Management Co., Ltd. claims investment losses of 5.147 billion yuan due to Kangde Xin's false statements from 2016 to 2021 and seeks compensation, including related commissions and taxes [3] - Sading Ningbo is listed as the seventh defendant in the lawsuit, primarily due to previous business dealings with Kangde Xin, but the company asserts it did not knowingly assist in any fraudulent activities [3][4] - The case involves eleven defendants, and China Chemical preliminarily assesses that it will not materially impact current or future profits [3][4] Group 2: Background on Kangde Xin - Kangde Xin was listed in July 2010 and specializes in the research and consulting of polymer composite materials and functional film materials [4] - The company was forced to delist in 2021 after it was found to have fabricated over 10 billion yuan in profits [4] - Zhejiang Zhongtai Chuangying became the second-largest shareholder of Kangde Xin after signing a strategic cooperation agreement in 2016, which was terminated in 2018 [4]

Group 1: Company Announcements - Heng Rui Pharmaceutical has completed its share repurchase plan, spending approximately 600 million yuan, repurchasing 12.9051 million shares, which is 0.20% of the total share capital, with an average repurchase price of about 46.59 yuan per share [1] - Chengdi Xiangjiang's wholly-owned subsidiary signed an EPC general contracting contract with China Mobile for a project worth 1.632 billion yuan, which is expected to positively impact future revenue [2] - Jingyuan Environmental Protection's wholly-owned subsidiary signed a contract for a computing cluster construction project worth 365 million yuan, with a gross profit margin of approximately 9% to 10% [3] Group 2: Legal and Regulatory Issues - China Chemical's subsidiary is involved in a lawsuit concerning false statements related to securities, with a claim for damages amounting to 5.147 billion yuan [4] - ST Huijin has applied to revoke its other risk warning status after addressing issues from a previous administrative penalty, pending approval from the Shenzhen Stock Exchange [5] Group 3: Stock Performance and Risks - Ningbo Shipping's stock has seen a significant short-term increase, with a cumulative price deviation exceeding 20% over three trading days, indicating potential trading risks [6] - Lianyungang's stock has also experienced a similar short-term price increase, with a 48.01% year-on-year decline in net profit for the first quarter [7] - Xinhua Jin has reported potential risks of administrative penalties or disciplinary actions from the China Securities Regulatory Commission due to uncertainties in export business [8]

Group 1 - China Chemical's subsidiary, China Chemical Siding Ningbo, is involved in a lawsuit regarding false securities statements by Kangde Xin, with a claim for 5.147 billion yuan in damages [2] - ST Huijin has applied to revoke its risk warning status after addressing issues from a previous administrative penalty, pending approval from the Shenzhen Stock Exchange [3] - Ningbo Ocean has stated that there are no undisclosed significant information and that its business operations remain normal despite recent stock price fluctuations [4] Group 2 - ST Dongyi's controlling shareholder, Dongyi Tianzheng Investment, is set to auction 32 million shares, representing 7.63% of the company's total shares, without affecting the company's control [5] - Jingyuan Environmental Protection's subsidiary has signed a 365 million yuan contract for a computing cluster construction project, with expected revenue recognition of approximately 320 million yuan upon project completion in 2025 [6]

Core Viewpoint - China National Chemical Engineering Co., Ltd. (China Chemical) is actively aligning with national strategies to enhance high-quality development, focusing on value creation and risk management while aiming for a stronger brand image and investor returns [2][3]. Group 1: Financial Performance - In 2024, China Chemical achieved an operating revenue of 185.84 billion yuan, representing a year-on-year growth of 4.20% [2]. - The net profit attributable to shareholders for 2024 was 5.688 billion yuan, with a year-on-year increase of 4.82%, indicating continuous optimization of profitability [2]. - In the first quarter of 2025, the company reported a net profit of 1.445 billion yuan, showing a significant year-on-year growth of 18.77%, reflecting improved operational quality [2]. Group 2: Strategic Initiatives - China Chemical is implementing a "dual-driven" model of technological and management innovation, which has led to profit growth significantly outpacing revenue growth [3]. - The company's overseas business has increased to over 30%, and new material industrialization projects are entering a phase of concentrated returns, indicating a strategic shift towards international markets and emerging sectors [3]. - The strategic layout is expected to translate into tangible performance drivers, helping China Chemical move towards its goal of becoming a globally competitive first-class enterprise [3].

Group 1 - The report highlights that the technology sector continues to lead, with advanced manufacturing capacity being gradually cleared, while the domestic demand sector is poised for recovery [6][11][14] - AI and military industries are driving demand expansion, while real estate and photovoltaic sectors are experiencing accelerated supply contraction [6][11][14] - In 2024, the A-share market is expected to see a significant increase in shareholder returns, with cash dividends and share buybacks becoming more prevalent [6][11][14] - The "export rush" effect is evident in Q1 2025, with caution advised for industries with significant exposure to risks from the U.S. [6][11][14] Group 2 - The basic chemical industry is experiencing a recovery in profitability due to inventory replenishment in Q1 2025, despite a decline in construction projects over the past two quarters [14][6] - Energy prices are expected to decline year-on-year in 2024, but terminal demand remains weak, leading to fluctuations in the price differentials within the basic chemical sector [14][6] - The report indicates that the overall profitability of the advanced manufacturing sector is at a historical low, with capital expenditures showing negative growth for four consecutive quarters [6][11][14] Group 3 - Hai Feng International is focusing on the Asian regional market, leveraging its operational stability to build a competitive moat in the small container ship market [17][3] - The company is expected to benefit from the acceleration of industrial transfer to Southeast Asia, which is projected to maintain strong long-term demand [17][3] - The supply of new small container ships is limited, which may lead to negative growth in capacity in the future [17][3] Group 4 - In the cloud computing sector, Microsoft Azure has shown a significant revenue increase, driven by both AI and non-AI business segments [16][18] - Google Cloud and Amazon AWS have also performed steadily, with their revenues meeting expectations [16][18] - The report notes that the overall capital expenditure of major tech companies is expected to grow significantly, indicating a positive outlook for the sector [19][20]

Group 1 - The company is currently valued at a historical low with a PB of 0.75, indicating strong safety margins [1] - The company has a low interest-bearing debt ratio of 6.3%, the lowest among the top eight state-owned construction enterprises, with cash assets of 39.7 billion yuan [1] - The company has consistently generated positive operating cash flow since its listing, with a total of 13.9 billion yuan in operating and investment cash flow over the past five years [1] Group 2 - The company's caprolactam project is progressing smoothly, benefiting from accelerated import substitution and declining raw material prices, which are expected to significantly enhance profitability [2] - The price of key raw materials for caprolactam, such as butadiene and natural gas, has decreased, leading to an estimated profit increase of 298 million yuan due to lower costs [2] - The company is focusing on a "technology + industry" integrated model, advancing several key pilot projects in new chemical materials and specialty chemicals [2] Group 3 - The domestic construction business is benefiting from accelerated investment in coal chemical projects, while overseas markets remain robust [3] - The company is expected to capture a significant share of the coal chemical investment, with projected annual investments of 117.7 billion yuan in 2025 and 210.4 billion yuan in 2026 [3] - The company signed overseas orders worth 113.3 billion yuan in 2024, continuing to grow from a high base last year, which will drive overall revenue and profit growth [3] Group 4 - The company is projected to achieve net profits of 5.7 billion yuan, 6.3 billion yuan, and 7.2 billion yuan from 2024 to 2026, with corresponding PE ratios of 7.9, 7.2, and 6.3 [4] - The company is recommended for investment due to the acceleration of overseas large orders, benefits from domestic coal chemical investment, and strong cash flow with potential for increased dividends [4]

Core Viewpoint - The company reported a steady operational performance in Q1 2025, with revenue growth but a decline in net profit, primarily due to fluctuations in chemical product prices and project revenue recognition delays [1][2]. Group 1: Financial Performance - In Q1 2025, the company achieved revenue of 548 million yuan, representing a year-on-year increase of 5.5% but a quarter-on-quarter decrease of 36.4% [1]. - The net profit attributable to shareholders was 52 million yuan, down 10.5% year-on-year and down 55.8% quarter-on-quarter [1]. - The company's gross margin and net margin were 20.6% and 9.2%, respectively, with a year-on-year increase of 0.8 percentage points and a decrease of 1.1 percentage points [3]. Group 2: Business Outlook - The chemical business is expected to benefit from the company's integrated layout in alcohols and esters, with a new production line for 50,000 tons of isooctanoic acid expected to contribute to growth within the year [2]. - The engineering business has a strong order backlog, with new contracts signed in Q1 totaling 474 million yuan, 117 times that of the same period last year [2]. - The company is positioned to capture more orders due to its geographical advantages, particularly with ongoing projects like the Northern Huajin order expected to be completed in 2025 [2]. Group 3: Strategic Initiatives - The company is advancing its cellulose derivatives project, which includes upgrading a 1,000 tons/year butyric acid cellulose facility to 15,000 tons/year capacity, aiming to benefit from domestic substitution opportunities [3]. - The company leads in sulfur recovery technology, having designed and contracted 240 sulfur recovery units with a total capacity of 12.83 million tons/year, making it the largest in this sector in China [4]. - Recent wins in Xinjiang's coal chemical sector are expected to drive rapid growth in performance, with multiple projects secured for sulfur recovery design and technical services [4]. Group 4: Profit Forecast - The company forecasts net profits attributable to shareholders of 416 million yuan, 525 million yuan, and 657 million yuan for 2025-2027, representing year-on-year growth rates of 58.5%, 26.0%, and 25.2%, respectively [4].